• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Pre-Market Assessment of Graphic Health Warnings (GHW) to Inform Campaigns

Description: Objective is to inform development of effective campaigns that educate the public, especially young people, about the dangers of tobacco use. This is a joint project with Office of Science (OS).

Accomplishment: This project is retired as ongoing litigation regarding Graphic Health Warnings is holding up implementation indefinitely

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

1. Analyze data from 2010 experimental study to further explore effectiveness of 9 selected images among subpopulations


Completed 11/30/2011

2. Establish time-sensitive research with NIH to investigate gaps in knowledge about the relative effective of the GHWs with various subpopulations.


Completed 11/30/2011

3. Establish baseline on GHWs through collaborative research with NIH.



Completed N/A

4. Conduct focus groups to fill in qualitative knowledge gaps not addressed through steps 1, 2, and 3.


Completed N/A

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.